Literature DB >> 23370374

Metabolic syndrome, diabetes, and hyperuricemia.

Changgui Li1, Ming-Chia Hsieh, Shun-Jen Chang.   

Abstract

PURPOSE OF REVIEW: To explore the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia. RECENT
FINDINGS: The prevalence of hyperuricemia in male adults with metabolic syndrome was increased and a large difference in prevalence of metabolic syndrome also existed in those with hyperuricemia compared with normouricemia. Even in those with normouricemia, higher serum uric acid levels were associated with metabolic syndrome. Serum uric acid was an independent risk factor for incident diabetes, and evidence showed that the patients with both gout and type 2 diabetes exhibited a mutual inter-dependent effect on higher incidences. Furthermore, obese patients often demonstrated insulin resistance and adipose tissue macrophage with low-grade inflammation, which is suggested to be the major contributor. Although alcohol intake is considered a risk for developing hyperuricemia, moderate alcohol intake showed a lower risk for developing type 2 diabetes and insulin resistance. Hyperinsulinemia reduces renal excretion of uric acid on the proximal tubular of the kidney leading to hyperuricemia, which has deleterious effects on endothelial function and on nitric oxide bioavailability, thus causing hyperinsulinemia.
SUMMARY: We found evidence to suggest that insulin resistance plays a potentially key role in the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia. Furthermore, it is likely that hyperuricemia and insulin resistance share a bidirectional causal effect.

Entities:  

Mesh:

Year:  2013        PMID: 23370374     DOI: 10.1097/BOR.0b013e32835d951e

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  110 in total

1.  β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.

Authors:  Emily L Goldberg; Jennifer L Asher; Ryan D Molony; Albert C Shaw; Caroline J Zeiss; Chao Wang; Ludmilla A Morozova-Roche; Raimund I Herzog; Akiko Iwasaki; Vishwa Deep Dixit
Journal:  Cell Rep       Date:  2017-02-28       Impact factor: 9.423

2.  Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population.

Authors:  Haoyu Wang; Yingxian Sun; Shuze Wang; Hao Qian; Pengyu Jia; Yintao Chen; Zhao Li; Lijun Zhang
Journal:  Clin Rheumatol       Date:  2018-05-16       Impact factor: 2.980

3.  Effects of febuxostat on insulin resistance and expression of high-sensitivity C-reactive protein in patients with primary gout.

Authors:  Juan Meng; Yanchun Li; Xiaoxu Yuan; Yuewu Lu
Journal:  Rheumatol Int       Date:  2016-11-23       Impact factor: 2.631

Review 4.  Optimizing current treatment of gout.

Authors:  Frances Rees; Michelle Hui; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

5.  The Power of Serum Uric Acid in Predicting Metabolic Syndrome Diminishes With Age in an Elderly Chinese Population.

Authors:  J-H Chen; C-H Hsieh; J-S Liu; T-J Chuang; H-W Chang; C-L Huang; P-F Li; D Pei; Y-L Chen
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

6.  Serum uric acid and risk of incident diabetes in middle-aged and elderly Chinese adults: prospective cohort study.

Authors:  Di Cheng; Chunyan Hu; Rui Du; Hongyan Qi; Lin Lin; Xueyan Wu; Lina Ma; Kui Peng; Mian Li; Min Xu; Yu Xu; Yufang Bi; Weiqing Wang; Yuhong Chen; Jieli Lu
Journal:  Front Med       Date:  2020-04-29       Impact factor: 4.592

7.  Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study.

Authors:  Li-Xin Tao; Xia Li; Hui-Ping Zhu; Da Huo; Tao Zhou; Lei Pan; Yan-Xia Luo; Wei Wang; Zhao-Ping Wang; Dong-Ning Chen; Li-Juan Wu; Xiu-Hua Guo
Journal:  Endocrine       Date:  2013-10-04       Impact factor: 3.633

Review 8.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

9.  Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study.

Authors:  Shuang Chen; Xiaofan Guo; Siyuan Dong; Shasha Yu; Yintao Chen; Naijin Zhang; Yingxian Sun
Journal:  Clin Rheumatol       Date:  2017-02-09       Impact factor: 2.980

10.  [Austrian 3e-recommendations for diagnosis and management of gout 2013].

Authors:  Judith Sautner; Johann Gruber; Manfred Herold; Jochen Zwerina; Burkhard F Leeb
Journal:  Wien Klin Wochenschr       Date:  2013-12-03       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.